Employment Opportunities


email this

Current Openings at the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID)

Duke University and Health System is an Equal Opportunity/Affirmative Action Employer

Postdoctoral Associate (Autophagy)

The Duke Human Vaccine Institute,occupying a place of national and international leadership in the fight against major infectious diseases, is currently recruiting for a Postdoctoral Associate.

As a ubiquitous cellular pathway essential for degrading and recycling proteins and organelles, autophagy has been implicated in a broad spectrum of human diseases and more recently in host-pathogen interactions. The research will focus on: 1) molecular mechanisms of infection-induced autophagy, and 2) the effects of autophagy on mycobacterial virulence and host immunity. The successful candidate is expected to be knowledgeable of standard molecular, cellular biology, and immunology techniques. The applicant must hold a Ph.D. or equivalent. Previous research experience in the autophagy field and immunology is a plus.

Only candidates who have received their PhD or equivalent within the last 24 months will be considered. 

Qualified candidates meeting the above criteria should send a cover letter, current CV, description of recent research work, and the names of three references (with phone number and email address) to:

Duke Human Vaccine Institute
Please reference “Lee-cell death” in the subject line of the email.

Research Technician II

The Research Technician II duties may include, data analysis, experimental design and method development; gene cloning, sequencing, cryopreservation, PCR, PBMC processing, transfections, and protein purification.  Other immunological assays include Western Blots, ELISA, and tissue culture. Applicants must possess a BA/BS in a physical or biological science with related experience.

Qualified candidates should submit a resume to:

DHVI Human Resources
Please note “RT II” in the subject line in the email.